StrataStem Limited logo

StrataStem Limited

StrataStem is an innovative spin-out biotech working at the forefront of Alzheimer's disease (AD) research and is developing intelligent phenotype-genotype (iPG) drug screening platforms to identify appropriate therapeutics for AD. StrataStem uses induced Pluripotent Stem Cells (iPSCs) derived from AD patients to rapidly isolate neural progenitor cells, using our patented technology, to create Alzheimer’s disease in a dish cell models.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.stratastem.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Suite 112, 4a Rylands Street, WA1 1EN
Warrington
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/stratastem-limited” connections=”true” suffix=””]